13F Holdings
中文EN

ASPI ASP Isotopes Inc.

Miscellaneous Chemical Products · Nasdaq · SEC CIK 1921865 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY552.4%
TTM net income YoY-28.0%
TTM EPS YoY0.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin19.4%
Operating margin-400.9%
Net margin-435.3%
FCF margin-322.6%
EBITDA margin-382.6%

Returns

ROE-63.9%
ROA-35.4%
ROIC (approx.)-107.2%
Asset turnover0.08x

Leverage & solvency

Liabilities / assets33.2%
Debt / equity0.15x
Current ratio3.44x
Interest coverage-17.04x

Cash quality & payout

Operating cash flow / net income0.62x
Accruals ratio-13.4%
Payout ratio—
Capex / revenue51.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20222022-12-30
Income statement
Revenue$23.85M$4.14M$433,026$0—
Cost of revenue$20.44M$2.54M$294,056$0—
Gross profit$3.40M$1.60M$138,970$0—
R&D expense$12.36M$3.14M$764,581$1.27M—
SG&A expense$48.24M$24.81M$15.42M$3.83M—
Operating income-$59.91M-$26.35M-$16.04M-$5.10M—
Interest expense$575,000$259,000$118,547$0—
Pretax income-$159.56M-$32.31M-$16.30M-$4.95M—
Income tax$282,000$111,000-$6,133$0—
Net income-$159.84M-$32.42M-$16.29M-$4.95M—
EBITDA-$58.00M-$25.88M-$16.00M-$5.10M—
EPS (basic)-2.11-0.63-0.49-0.18-0.18
EPS (diluted)-2.11-0.63-0.49——
Weighted avg. shares (diluted)83.01M55.67M33.07M——
Banking
Net interest income———$3,382—
Balance sheet
Cash & equivalents$279.57M$61.89M$7.91M$2.39M—
Short-term investments$47.74M$0———
Receivables——$216,504——
Inventory$1.10M$66,000$0——
Current assets$399.92M$65.74M$10.51M$3.30M—
PP&E, net$33.29M$22.35M$10.71M$8.20M—
Goodwill$5.18M$3.17M$3.27M$0—
Intangibles$675,000————
Total assets$498.02M$94.35M$27.54M$12.50M—
Current liabilities$32.70M$7.06M$5.67M$1.94M—
Short-term debt$584,000$939,000———
Long-term debt$1.47M$1.44M———
Total debt$2.06M$2.38M———
Total liabilities$235.12M$43.18M$8.71M$2.68M—
Shareholders' equity$204.15M$47.90M$16.30M$9.82M—
Net debt-$277.52M-$59.51M———
Shares outstanding111.68M72.07M48.92M35.91M—
Cash flow statement
Operating cash flow-$37.78M-$16.70M-$5.41M-$2.94M—
Capital expenditure$9.65M$9.68M$2.33M$4.47M—
Free cash flow-$47.43M-$26.37M-$7.74M-$7.41M—
Investing cash flow-$110.79M-$11.37M-$2.45M-$4.47M—
Financing cash flow$371.60M$82.53M$13.39M$6.64M—
Depreciation & amortization$1.91M$471,000$37,433$0—
Stock-based compensation$16.02M$8.56M$8.74M$2.00M—
Dividends paid$0$2.78M$0——

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.